- Home
- ACIC vs QSI Comparison
ACIC vs QSI Comparison
Compare ACIC & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACIC
- QSI
- Stock Information
- Founded
- ACIC 1999
- QSI 2013
- Country
- ACIC United States
- QSI United States
- Employees
- ACIC N/A
- QSI N/A
- Industry
- ACIC Property-Casualty Insurers
- QSI Biotechnology: Pharmaceutical Preparations
- Sector
- ACIC Finance
- QSI Health Care
- Exchange
- ACIC Nasdaq
- QSI Nasdaq
- Market Cap
- ACIC 588.1M
- QSI 288.2M
- IPO Year
- ACIC N/A
- QSI N/A
- Fundamental
- Price
- ACIC $11.92
- QSI $1.92
- Analyst Decision
- ACIC Buy
- QSI Buy
- Analyst Count
- ACIC 1
- QSI 2
- Target Price
- ACIC $16.00
- QSI $3.25
- AVG Volume (30 Days)
- ACIC 156.1K
- QSI 24.0M
- Earning Date
- ACIC 02-27-2025
- QSI 02-27-2025
- Dividend Yield
- ACIC 4.18%
- QSI N/A
- EPS Growth
- ACIC N/A
- QSI N/A
- EPS
- ACIC 1.76
- QSI N/A
- Revenue
- ACIC $290,784,000.00
- QSI $2,266,000.00
- Revenue This Year
- ACIC N/A
- QSI $193.90
- Revenue Next Year
- ACIC $12.68
- QSI $173.18
- P/E Ratio
- ACIC $6.77
- QSI N/A
- Revenue Growth
- ACIC 1.02
- QSI 232.26
- 52 Week Low
- ACIC $8.82
- QSI $0.61
- 52 Week High
- ACIC $15.08
- QSI $5.77
- Technical
- Relative Strength Index (RSI)
- ACIC 38.97
- QSI 42.87
- Support Level
- ACIC $11.81
- QSI $2.26
- Resistance Level
- ACIC $12.66
- QSI $2.12
- Average True Range (ATR)
- ACIC 0.32
- QSI 0.25
- MACD
- ACIC 0.00
- QSI -0.11
- Stochastic Oscillator
- ACIC 10.38
- QSI 7.53
About ACIC American Coastal Insurance Corporation
American Coastal Insurance Corp is a holding company that underwrites commercial residential property and casualty insurance policies in the United States through its wholly-owned insurance subsidiary. The company has two segments namely: Commercial Lines Business and Personal Lines Business. It derives maximum revenue from Commercial Lines Business Segment.
About QSI Quantum-Si Incorporated
Quantum-Si Inc is focused on revolutionizing the growing field of proteomics. The company's suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable single-molecule next-generation protein sequencing and genomics, and digitize proteomic research in order to advance drug discovery and diagnostics beyond DNA sequencing.